MidCap Growth Fund

Overview

Objective

Seeks capital appreciation.

Strategy

Invests in a diversified portfolio of equity securities of medium-sized companies that show the potential for above-average growth in earnings.

The Management Team

The Fund is managed by the Equity Strategy Team, a group of senior-level investment professionals who average 35 years of experience.

Risk/Return

LOW - - - - - • - HIGH

In general, greater returns are associated with greater risks.

Fund Statistics

Inception Date 12/12/94
Ticker Symbol CFAGX
Cusip 200626505
Minimum Initial Investment $1,000

Commentary

In the first quarter, market volatility continued, fueled by rising interest rates, however, with additional fiscal stimulus and better than anticipated COVID-19 vaccine rollout the equity markets climbed higher.

For the first quarter, The Commerce Mid Cap Growth Fund’s return of 3.87% outperformed the Russell Mid Cap Growth Index of -0.57%.

Stock selection was the largest contributor to the Fund’s outperformance. The Fund’s strongest stocks were Teradata Corporation (0.00%), Penumbra, Inc. (1.19%), Laboratory Corporation of America (1.17%) and Landstar System, Inc. (1.17%) returning 78.86%, 54.62%, 25.29%, and 24.45%, respectively. The Fund’s top detractors were Chemed Corporation (1.15%) and Black Knight, Inc. (1.16%) returning -13.60% and -16.25%, respectively.

The Fund’s sector allocations slightly detracted from performance. The Fund was 4.36% underweight the Index’s weight of 10.73% in the Consumer Discretionary, which returned 6.77%. However, the Fund’s 0.9% overweight to the Real estate sector which was the top performing sector returning 22.25% helped performance. The Index had a 1.51% weight to the Real Estate sector.

Total Fund Assets as of 3/31/2021 $303,736,517
Net Asset Value1 $53.08
Asset Allocation  
Equities 99.1%
Cash 0.9%
Weighted Average Market Capitalization 19.86 Billion

Holdings

Top Ten Equity Holdings2 as of 3/31/2021

iShares Russell MidCap Growth 2.5%
Lumentum Holdings Inc
1.4%
Guardant Health Inc
1.3%
Abiomed, Inc
1.3%
Netapp Inc
1.3%
KLA Corporation
1.3%
Entegris Inc
1.3%
Dollar Tree Inc
1.3%
Teradyne Inc
1.3%
PTC Inc
1.3%

Footnotes:
1. The Net Asset Value represents the assets of the fund (ex dividend) by the total number of shares.
2. The composition of the portfolio is subject to change in the future.
3. The Russell 1000 Growth Index is an unmanaged index that measures the performance of those Russell 1000 companies with higher price-to-book ratios and higher forecasted growth values. The Index figures do not reflect any fees or expenses.

Portfolio Holdings

The Fund invests in mid-capitalization securities. The securities of mid-capitalization companies involve greater risks than those associated with larger, more established companies and may be subject to more abrupt or erratic price movements.

Holdings and allocations shown are unaudited, and may not be representative of current or future investments. Holdings and allocations may not include the Fund's entire investment portfolio, which may change at any time. Fund holdings should not be relied on in making investment decisions and should not be construed as research or investment advice regarding particular securities.

Commerce MidCap Growth Holdings

February 2021*
March 2021*
April 2021*

A prospectus for the Commerce Funds containing more complete information may be obtained by calling 1-800-995-6365 or by downloading it from this website. Please consider a Fund's objectives, risks, and charges and expenses, and read the prospectus carefully before investing. The prospectus contains this and other information about the Fund.

The mutual funds referred to in this Web site are offered and sold only to persons residing in the United States and are offered by prospectus only. The prospectus contains more complete information about the funds, including charges and expenses, and should be read carefully before investing.

The method of calculation of the 30-Day Standardized Subsidized Yield is mandated by the Securities and Exchange Commission and is determined by dividing the net investment income per share earned during the last 30 days of the period by the maximum public offering price (“POP”) per share on the last day of the period. This number is then annualized. The 30-Day Standardized Subsidized Yield reflects fee waivers and/or expense reimbursements recorded by the Fund during the period. Without waivers and/or reimbursements, yields would be reduced. This yield does not necessarily reflect income actually earned and distributed by the Fund and, therefore, may not be correlated with the dividends or other distributions paid to shareholders. The 30-Day Standardized Unsubsidized Yield does not adjust for any fee waivers and/ or expense reimbursements in effect. If the Fund does not incur any fee waivers and/or expense reimbursements during the period, the 30-Day Standard Subsidized Yield and 30-Day Standardized Unsubsidized Yield will be identical.